Progression parameters for emphysema: A clinical investigation

Respiratory Medicine

Volumn 101, Issue 9, 2007, Pages 1924-1930

  Stolk, Jan ^a   Putter, Hein ^a   Bakker, Els M ^a   Shaker, Saher B ^b   Parr, David G ^c   Piitulainen, Eeva ^d   Russi, Erich W ^e   Grebski, Elzbieta ^e   Dirksen, Asger ^b   Stockley, Robert A ^c   Reiber, Johan H C ^a   Stoel, Berend C ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

^e UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Airflow limitation; Alveolar destruction; Lung densitometry

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CARBON MONOXIDE; CORTICOSTEROID; LONG ACTING DRUG; TIOTROPIUM BROMIDE;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONFIDENCE INTERVAL; DENSITOMETRY; DIFFUSION COEFFICIENT; DISEASE COURSE; EMPHYSEMA; FEMALE; FORCED EXPIRATORY VOLUME; GAS DIFFUSION; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; INTERMETHOD COMPARISON; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROGNOSIS; SENSITIVITY ANALYSIS; SIGNAL NOISE RATIO; SPIROMETRY;

ADULT; AGED; ALPHA 1-ANTITRYPSIN DEFICIENCY; CARBON MONOXIDE; DENSITOMETRY, X-RAY; DISEASE PROGRESSION; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PULMONARY EMPHYSEMA; SPIROMETRY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34547476189     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2007.04.016     Document Type: Article

References (24)

1. Pauwels R.A., and Rabe K.F. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 364 (2004) 613-620
2. Fletcher C., and Peto R. The natural history of chronic airflow obstruction. Br Med J 1 (1997) 1645-1648
3. 1. J Am Med Assoc 272 (1994) 1497-1505
4. Decramer M., Rutten-van Molken M., Dekhuijzen P.N., Troosters T., van Herwaarden C., Pellegrino R., et al. Effects of N-acetylcysteine on outcome in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial. Lancet 365 (2005) 1552-1560
5. Dirksen A., Dijkman J.H., Madsen F., Stoel B.C., Hutchison D.C., Ulrik C.S., et al. A randomized clinical trial of alpha-1-antitrypsin augmentation therapy. Am J Respir Crit Care Med 160 (1999) 1468-1472
6. Rabe K.F., Bateman E.D., O'Donnell D., Witte S., Bredenbroker D., and Bethke T.D. Roflumilast-an oral anti-inflammatory treatment for chronic obstructive pulmonary disease (COPD). Lancet 366 (2005) 563-571
7. Hayhurst M.D., MacNee W., Flenley D.C., Wright D., McLean A., Lamb D., et al. Diagnosis of pulmonary emphysema by computerised tomography. Lancet 2 (1984) 320-322
8. Gevenois P.A., DeVuyst P., de Maertelaer V., Zanen J., Jacobovits D., Cosio M.G., et al. Comparison of computed density and microscopic morphometry in pulmonary emphysema. Am J Respir Crit Care Med 154 (1996) 187-192
9. Gould G.A., MacNee W., McLean A., Warren P.M., Redpath A., Lamb D., et al. CT measurements of lung density in life can quantitate distal airspace enlargement-an essential defining feature of human emphysema. Am Rev Respir Dis 137 (1988) 380-392
10. Coxson H.O., Mayo J.R., Behzad H., Moore B.J., Verburgt L.M., Staples C.A., et al. Measurement of lung expansion with computed tomography and comparison with quantitative histology. J Appl Physiol 79 (1995) 1525-1530
11. Muller N.L. Chronic obstructive pulmonary disease-4: imaging the lungs in patients with chronic obstructive pulmonary disease. Thorax 57 (2002) 982-985
12. Newell J.D., Hogg J.C., and Snider G.L. Report of a workshop: quantitative computed tomography scanning in longitudinal studies of emphysema. Eur Respir J 23 (2004) 769-775
13. Bakker M.E., Stolk J., Putter H., Shaker S.B., Parr D.G., Piitulainen E., et al. Variability in densitometric assessment of pulmonary emphysema with computed tomography. Invest Radiol 40 (2005) 777-783
14. DerSimonian R., and Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 7 (1986) 177-188
15. Barnes P.J., and Stockley R.A. COPD: current therapeutic interventions and future approaches. Eur Respir J 25 (2005) 1084-1106
16. Hogg J.C., Macklem P.T., and Thurlbeck W.M. Site and nature of airway obstruction in chronic obstructive lung disease. N Engl J Med 278 (1968) 1355-1360
17. Rousson V., Gasser T., and Seifert B. Assessing intrarater, interrater and test-retest reliability of continuous measurements. Statist Med 21 (2002) 3431-3436
18. Hogg J.C., Chu F., Utokaparch S., Woods R., Elliot W.M., Buzatu L., et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 350 (2004) 2645-2653
19. Rosenblum L.J., Mauceri R.A., Wellenstein D.E., Thomas F.D., Bassano D.A., Raasch B.N., et al. Density patterns in normal lung as determined by computed tomography. Radiology 137 (1980) 409-416
20. Dirksen A., Friis M., Olesen K.P., Skovgaard L.T., and Sorensen K. Progress of emphysema in severe alpha-1-antitrypsin deficiency as assessed by annual CT. Acta Radiol 38 (1997) 826-832
21. Kemerink G.J., Kruize H.H., Lamers R.J., and van Engelshoven J.M. Density resolution in quantitative computed tomography of foam and lung. Med Phys 23 (1996) 1697-1708
22. Tager I.B., Segal M.R., Speizer F.E., and Weiss S.T. The natural history of forced expiratory volumes effect of cigarette smoking and respiratory symptoms. Am Rev Respir Dis 138 (1988) 837-849
23. Sherrill D.L., Enright P.L., Kaltenborn W.T., and Lebowitz M.D. Predictors of longitudinal change in diffusing capacity over 8 years. Am J Respir Crit Care Med 160 (1999) 1883-1887
24. Watson A., Joyce H., and Pride N.B. Changes in carbon monoxide transfer over 22 years in middle-aged men. Respir Med 94 (2000) 1103-1108